Copyright
©2011 Baishideng Publishing Group Co.
World J Clin Oncol. Dec 10, 2011; 2(12): 377-383
Published online Dec 10, 2011. doi: 10.5306/wjco.v2.i12.377
Published online Dec 10, 2011. doi: 10.5306/wjco.v2.i12.377
Trial | Phase | Pts | Study design | Main end-point | Results |
Lin JC et al[4] | III | 284 | Exclusive RT alone vs cDDP-5FU + RT | 5-year DFS | Experimental arm better (P < 0.0012) |
Chan AT et al[5] | III | 350 | Exclusive RT alone vs cDDP-5FU + RT | 2-year PFS | Experimental arm better (P < 0.016) |
Zhang L et al[12] | III(m) | 1608 | Exclusive RT alone vs cDDP based CT + RT | 5-year OS | Experimental arm better (P < 0.001) |
Yang AK et al[13] | III(m) | 1993 | Exclusive RT alone vs cDDP based CT + RT | 5-year OS | Experimental arm better (P < 0.05) |
Lu H et al[17] | II | 22 | IMRT + cDDP | 1 year OS | 96% |
Ekenel M et al[34] | II | 100 | IMRT+ cDDP-Cet | ORR | 100% |
- Citation: Perri F, Bosso D, Buonerba C, Lorenzo GD, Scarpati GDV. Locally advanced nasopharyngeal carcinoma: Current and emerging treatment strategies. World J Clin Oncol 2011; 2(12): 377-383
- URL: https://www.wjgnet.com/2218-4333/full/v2/i12/377.htm
- DOI: https://dx.doi.org/10.5306/wjco.v2.i12.377